Lord, Abbett & Co’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-667,881
| Closed | -$18M | – | 544 |
|
|
2025
Q1 | $18M | Sell |
667,881
-599,922
| -47% | -$16.2M | 0.06% | 296 |
|
|
2024
Q4 | $67.9M | Buy |
1,267,803
+564,322
| +80% | +$30.2M | 0.21% | 129 |
|
|
2024
Q3 | $32M | Buy |
703,481
+874
| +0.1% | +$39.7K | 0.1% | 246 |
|
|
2024
Q2 | $29.4M | Buy |
702,607
+160,234
| +30% | +$6.71M | 0.1% | 251 |
|
|
2024
Q1 | $20.4M | Buy |
+542,373
| New | +$20.4M | 0.07% | 331 |
|